Cancers Treated:
Specializing In:
Immunotherapy Clinical trials in early and advanced prostate cancerAbout Gurkamal Chatta
Positions
Roswell Park Comprehensive Cancer Center
- Professor of Oncology
- Clinical Chief of Genitourinary Medicine
Background
Education and Training:
- 1981 – MBBS – University College of Medical Sciences, Delhi University, Delhi, India
Residency:
- 1988 – Internal Medicine – Mount Sinai Medical Center, University of Wisconsin, Medical School, Milwaukee Clinical Campus, Milwaukee, WI
- 1982 – Medicine, Surgery and Intensive Care – Safdarjang Hospital, Delhi University, Delhi, India
Fellowship:
- 1996 – Divisions of Hematology and Oncology – University of Washington School of Medicine, Seattle, WA
- 1992 – Division of Gerontology – University of Washington School of Medicine, Seattle, WA
Clinical Trials
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Learn More
EPI-7386 in Combination With Enzalutamide Compared With Enzalutamide Alone in Subjects With mCRPC
Learn More
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Learn More
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
Learn More
Featured on Cancer Talk
Showing all3 of 6 CollapseView all